Instil Bio, Inc.

TIL Healthcare Biotechnology

In the quarter to June 2026, EPS grew 80.6%, free cash flow grew 68.6% and total debt was flat, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.

5.91 0.22 −3.59%
Market cap
$41.6M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Total current assets
191.43 124.47 160.76 269.38 464.02 246.14 9.29
Total non-current assets
12.09 139.10 164.87 212.75 145.96 72.87 0.19
Total Assets
203.52 263.57 325.63 482.13 609.98 319.01 9.48
Total current liabilities
4.84 7.90 10.56 32.79 41.36 13.28 1.42
Total non-current liabilities
84.81 86.24 89.24 85.74 13.43 345.33 14.95
Total liabilities
89.66 94.13 99.80 118.52 54.78 358.61 16.37
Common Equity (Total)
113.87 169.44 225.83 363.61 555.20 (39.60) (6.89)
Shareholders Equity (Total)
113.87 169.44 225.83 363.61 555.20 (39.60) (6.89)
Total Debt
84.81 84.19 81.43 72.35 — — —

Show all line items

In millions of $ except per-share values · columns are period end dates